Boston Collaborative Drug Surveillance Program

1966-1991

There are 239 publications from the BCDSP between 1966 and 1990. A list of these, including abstracts, has been published separately:

Cohen MR, Weaver J. A compilation of abstracts and an index of articles published by the Boston Collaborative Drug Surveillance Program 1966-1991. Hospital Pharmacy 1992; 27: S3- S55.

If you are interested in any of those earlier publications, please send us email to request a reprint of this summary or of any individual publications.

1992-2009

The following list contains all publications by the BCDSP and collaborators after 1991 in descending chronological order:

 2009

• Jick SS, Hagberg KW, Kaye JA, Jick H. Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer. Obstet Gynecol 2009;113(1):74-90.
• Jick H, Hagberg KW, Egger P. Rate of suicide in patients taking montelukast. Pharmacotherapy 2009;29(2):165-166.
• Becker C, Brobert G, Almqvist P, Johansson S, Jick SS, Meier CR. Migraine and the risk of stroke, asthma or death in the United Kingdom. Headache (in press).
• Brauchli Y, Curtin F, Jick SS, Meier CR. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis. J Am Acad Dermatol (in press).
• Osman M, Black C, Jick S, Hannaford PC. Previous maternal oral contraception and the risk among subsequent offspring of asthma diagnosis in early childhood. Paediatric and Perinatal Epidemiology (in press).
• Becker C, Brobert G, Almqvist P, Johansson S, Jick SS, Meier CR. A population-based study on migraine incidence, comorbidities and health resource utilisation in the United Kingdom. Cephalalgia (in press).
• Becker C, Jick SS, Meier CR. Use of statins or other lipid-lowering agents and the risk of Parkinson’s disease. Drug Safety (in press).
• Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and the risk of incident myocardial infarction, stroke, or transient ischemic attack: an inception cohort with a nested case-control analysis. Br J Dermatol (in press).
• Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR. Metformin, sulfonylureas or other antidiabetic drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care (in press).
• Brauchli YB, Jick SS, Curtin F, Meier CR. Lithium, antipsychotics and the risk of psoriasis. J Clin Psychopharmacol (in press).
• Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol (in press).
• Jick SS, Hagberg KW, Kaye JA, Jick H. The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the U.K. General Practice Research Database. Contraception (in press).
• Schoonen WM, Kucera G, Coalson J, Li L, Rustein M, Mowat F, Fryzek, Kaye JA. Epidemiology of immune thrombocytopaenic purpura (ITP) in the General Practice Research Database. Br J Haematol (in press).

 2008

• Meier C, Kraenzlin ME, Bodmer M, Jick SS, Jick H, Meier CR. Use of thiazolidinediones and fracture risk. Arch Intern Med 2008;168:820-825.
• Jick SS, Li L. Antidepressant drugs in relation to venous thromboembolism. Pharmacotherapy 2008;28(2):144-150.
• Kaye JA, Jick H. Proton pump inhibitors and hip fractures in patients without major risk factors. Pharmacotherapy 2008;28:951-959.
• Becker C, Brobert G. Almqvist P, Johansson S, Jick SS, Meier CR. The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescription. Headache 2008;48:606-610.
• Jick SS, Choi H, Li L, McInnes I, Sattar N. Hyperlipidemia, statin use and the risk of developing rheumatoid arthritis. Ann Rheum Dis 2008 Jul 28 (Epub ahead of print)
• Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008;159:895-902. [2008 Jul 1 (Epub ahead of print)]
• Brauchli Y, Curtin P, Jick SS, Meier CR. Beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. Br J Dermatol 2008;158:1299-1307.
• Becker C. Jick SS, Meier CR. Use of antihypertensives and the risk of Parkinson’s disease. Neurology 2008;70:1438-1444.

 2007

• Ulcickas Yood M, Campbell UB, Rothman KJ, Jick SS, Lang J, Wells KE, Jick H, Johnson CC. Using prescription claims data for drugs available over the counter (OTC). Pharmacoepidemiology & Drug Safety 2007;16:961-968.
• Jick SS, Kaye JA, Li L, Jick H. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of contraceptives containing 35 µg ethinyl estradiol. Contraception 2007;76:4-7.
• Alonso A, Jick SS, Olek MJ, Hernán MA. Incidence of multiple sclerosis in the United Kingdom: findings from a population-based cohort. J Neurol 2007;254:1736-41.
• Jick SS, Kaye JA, Jick H. Diclofenac and acute myocardial infarction in patients with no major risk factors. Br J Clin Pharmacol 2007;64:662-7.
• Jick SS, Jick H. The contraceptive patch in relation to ischemic stroke and acute myocardial infarction. Pharmacotherapy 2007;27:218-220.
• Jick SS, Kaye JA, Jick H. Cardiovascular safety of cyclo-oxygenase-2 inhibitors. Lancet 2007;369:555-556.
• Schlienger RG, Fedson DS, Jick SS, Jick H, Meier CR. Statins and the risk of pneumonia: a population-based nested case-control study. Pharmacotherapy 2007;325-332. 

 2006

• Jick H, Kaye JA, Russmann S, Jick SS. Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors. Pharmacotherapy 2006;26:1379-1387.
• Jick SS, Jick H. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch. Contraception 2006;74:290-292.
• Schlienger RG, Fedson DS, Jick SS, Jick H, Meier CR. Statins and the risk of pneumonia: a population-based nested case-control study. Pharmacotherapy 2007;27:325-332.
• Alonso A, Jick SS, Jick H, Hernán MA. Antibiotic use and risk of multiple sclerosis. Am J Epidemiol 2006;163:997-1002.
• Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Contraception 2006;73:566-570.
• Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 µg of ethinyl estradiol. Contraception 2006;73:223-228. 
• Alonso A, Jick SS, Hernán MA. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 2006;66:572-575.
• Jick H, Beach KJ, Kaye JA. Incidence of autism over time. Epidemiol 2006;17:120-1.
• Hernán MA, Jick SS. Hepatitis B vaccination and multiple sclerosis: the jury is still out (editorial). Pharmacoepidemiology & Drug Safety 2006;15:653-655.
• Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Care & Research 2006;55:19-26.

 2005

• Gasse C, Hollowell J, Meier CR, Haefeli WE. Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin. Thromb Haemost 2005;94:537-543.
• Fischer LM, Schlienger RG, Matter CM, Jick H, Meier CR. Current use of nonsteroidal anti-inflammatory drugs and the risk of acute myocardial infarction. Pharmacotherapy 2005;25:503-510.
• Alonso A, Jick SS, Olek MJ, Ascherio A, Jick H, Hernán MA. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurology 2005;62:1362-1365.
• Currin L, Schmidt U, Treasure J, Jick H. Time trends in eating disorder incidence. Brit J Psychiatry 2005;186:132-135.
• Black C, Kaye JA, Jick H. Delivery by caesarean section in the UK: time trends in the General Practice Research Database. Obstet Gynecol 2005;106:151-155.
• Bradbury BD, Lash TL, Kaye JA, Jick SS. Tamoxifen-treated breast cancer patients and the risk of acute myocardial infarction and newly-diagnosed angina. Cancer 2005;103:1114-1121.
• Kaye JA, Jick H. Antibiotics and the risk of breast cancer. Epidemiol 2005;16:688-690.
• Russmann S, Kaye JA, Jick SS, Jick H. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database. Brit J Clin Pharmacol 2005;60:76-82.
• Bradbury BD, Wilk JB, Kaye JA. Obesity and the risk of prostate cancer. Cancer Causes and Control 2005;16:637-641.
• Hernán MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H.  Cigarette smoking and the progression of multiple sclerosis. Brain 2005;128:1461-1465.

 2004

• Peng M, Jick H. A population-based study of the incidence, cause and severity of anaphylaxis in the United Kingdom. Arch Int Med 2004;164:317-319.
• Schlienger RG, Fischer LM, Jick H, Meier CR. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Safety 2004;27:1157-1165.
• Fischer LM, Schlienger RG, Matter CM, Jick H, Meier CR. Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction. Arch Intern Med 2004;164:2472-2476.
• Jick H, Kaye JA, Black C. Incidence and prevalence of drug-treated attention deficit disorder in the UK.  Brit J Gen Prac 2004;54:345-347.
• Schlienger RG, Jick SS, Meier CR. Inhaled corticosteroids and the risk of fractures in children and adolescents. Pediatrics 2004;114:469-473.
• Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time myocardial infarction. Am J Cardiol  2004;93:198-200.
• Meier CR, Wilcock K, Jick SS. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Safety 2004;27:200-213.
• Miller DP, Kaye JA, Shea K, Ziyadeh N, Cali C, Black C, Walker AM. Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Epidemiology 2004;15:208-215.
• Kaye JA, Jick H. Statin use and cancer risk in the General Practice Research Database. Brit J Cancer 2004;90:635-7.
• Jick SS, Bradbury BD. Statins and newly diagnosed diabetes. Brit J Clin Pharmacol 2004;58:303-309.
• Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA 2004;292:338-343.
• Bradbury BD, Jick H. In vitro fertilization and childhood retinoblastoma. Brit J Clin Pharmacol 2004;58:209-211.
• Bradbury BD, Lash TL, Kaye JA, Jick SS. Tamoxifen and cataracts: a null association. Breast Cancer Research and Treatment 2004;87:189.
• Kaye JA, Jick H. Autism and DPT vaccine in the UK (letter). N Engl J Med 2004;350:2722-3.
• Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis. A prospective study. Neurology 2004;63:838-842.
• Schlienger RG, Kraenzlin ME, Jick S, Meier CR. Use of beta-blockers and risk of fractures. JAMA 2004;292:1326-1332.
• Kaye JA, Jick H. Epidemiology of lower limb fractures in general practice in the United Kingdom. Injury Prev 2004;10:368-374.
• Jick H. Side Effects of Drugs Essay: The General Practice Research Database. In: Aronson JK, ed. Side Effects of Drugs, Annual 27. Amsterdam, The Netherlands: Elsevier; 2004.

 2003

• Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopenic purpura.  Brit J Clin Pharmacol 2003;55:107-111.
• Wood SL, Jick H, Sauve R. The risk of stillbirth in pregnancies before and after the onset of diabetes. Diabetic Medicine 2003;20:703-707.
• Toledano MB, Hansell AL, Jarup L, Quinn M, Jick S, Elliott P. Temporal trends in orchidopexy, Great Britain, 1992-1998. Environ Health Perspect 2003;111:129-132.
• Yang CC, Jick SS, Jick H. Lipid-lowering drugs and the risk of depression and suicidal behavior. Arch Int Med 2003;163:1926-1932.
• Yang CC, Jick SS, Testa MA. Who receives lipid-lowering drugs: effects of comorbidities and patient characteristics on treatment initiation. Brit J Clin Pharmacol 2003;55:288-298.
• Yang CC, Jick SS, Testa MA. Discontinuation and switching of therapy after initiation of lipid-lowering drugs: The effect of comorbidities and patient characteristics. Brit J Clin Pharmacol 2003;56:84-91.
• Kaye JA, Jick H. Incidence of erectile dysfunction and characteristics of patients before and after the introduction of sildenafil in the United Kingdom: cross sectional study with comparison patients. BMJ 2003;326:424-5.
• Jick SS, Kaye JA, Vasilakis-Scaramozza C, García Rodríguez LA, Ruigómez A, Meier CR, Schlienger RG, Black C, Jick H. Validity of the General Practice Research Database. Pharmacotherapy 2003;23:686-9.
• Schlienger RG, Meier CR. HMG-CoA reductase inhibitors in osteoporosis.  Do they reduce the risk of fracture? Drugs Aging 2003;20:321-336.
• Jick H, Kaye JA, Black C. Changes in risk of autism in the UK for birth cohorts 1990-1998. Epidemiology 2003;14:630-632.
• Kaye JA, Bradbury BD, Jick H. Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: A population-based observational study. Brit J Clin Pharmacol 2003;56:569-575.
• Jick H, Kaye JA. The epidemiology and possible causes of autism. Pharmacotherapy 2003;23:1524-1530.

 2002

• Yang CC, Jick SS, Jick H. Statins and the risk of idiopathic venous thromboembolism. Brit J Clin Pharmacol 2002;53:101-105.
• Kaye JA, Meier CR, Walker AM, Jick H. Statin use, hyperlipidemia, and the risk of breast cancer. Brit J Cancer 2002;86:1436-39.
• Meier CR, Schmitz S, Jick H. Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy 2002;22:303-309.
• Kornegay CJ, Vasilakis-Scaramozza C, Jick H. Incident diabetes associated with antipsychotic drug use in the United Kingdom General Practice Research Database. J Clin Psychiatry 2002;63:758-762.
• Black C, Kaye JA, Jick H. Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill. Brit J Clin Pharmacol 2002;53:637-40.
• Meier CR, Krähenbühl S, Schlienger RG, Jick H. Association between body mass index and liver disorders: an epidemiological study. J Hepatol 2002;37:741-7.
• Schlienger RG, Jick H, Meier CR. Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. Brit J Clin Pharmacol 2002;54:327-332.
• Black C, Kaye JA, Jick H. The relation of childhood gastrointestinal disorders to autism: a nested case-control study using data from the UK General Practice Research Database. BMJ 2002;325:419-21.
• Bradbury BD, Jick SS. Itraconazole and fluconazole and certain rare, serious adverse events. Pharmacotherapy 2002;22:697-700.
• Ruigómez A, Johansson S, Wallander MA, García Rodríguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002;55:358-63.
• Lanes S, García Rodríguez LA, Huerta C. Respiratory medications and risk of asthma death. Thorax 2002;57:683-6.
• Huerta C, García Rodríguez LA, Wallander MA, Johansson S. Risk of irritable bowel syndrome among asthma patients. Pharmacoepidemiol & Drug Saf 2002;11:31-5.
• Huerta C, García Rodríguez LA. Risk of clinical blood dyscrasia in a cohort of antibiotic users. Pharmacotherapy 2002;22:630-6.
• Black C, Jick H. Etiology and frequency of rhabdomyolysis. Pharmacotherapy 2002;22:1524-1526.

 2001

• Seshadri S, Zornberg GL, Derby LE, Myers, MW, Jick H, Drachman DA. Postmenopausal estrogen replacement therapy and the risk of Alzheimer’s disease. Arch Neurol 2001;58:435-440.
• García Rodríguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs: a new population based study. Epidemiology 2001;12:88-93.
• Gaist D, Garcia Rodriguez LA, Huerta C, Hallas J, Sindrup SH. Are users of lipid lowering drugs at increased risk of peripheral neuropathy? European Journal of Clinical Pharmacology. 2001;56:931-933.
• García Rodríguez LA, Hernández-Díaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen and combination of these agents. Arthritis Research. 2001;3:98-101.
• Hernández-Díaz S, García Rodríguez LA. Steroids and risk of upper gastrointestinal complications. American Journal of Epidemiology. 2001;153(11):1089-93.
• Gaist D, García Rodríguez LA, Huerta C, Hallas J, Sindrup SH. Lipid lowering drugs and risk of myopathy: a population-based follow up study. Epidemiology 2001;12:565-569.
• Johansson S, Wallander MA, Ruigómez A, García Rodríguez LA. Incidence of newly diagnosed heart failure in general practice. European Journal of Heart Failure. 2001;3:225-231.
• García Rodríguez LA, Hernández-Díaz S. The risk of upper gastrointestinal complications among users of acetaminophen and non-steroidal anti-inflammatory drugs. Epidemiology. 2001;12:570-576.
• Huerta C, García Rodríguez LA, Ström-Möller C, Arellano F. The risk of obstructive airways disease in a glaucoma population. Pharmacoepidemiology and Drug Safety. 2001;10:157-163.
• Huerta C, García Rodríguez LA. Incidence of ocular melanoma in the general population and in glaucoma patients. J Epidemiol & Community Health 2001;55:338-9.
• De Abajo FJ, García Rodríguez LA. Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clinical Pharmacology. 2001; 1:1.
• Jick SS, Vasilakis-Scaramozza C, Maier WC. The risk of cataract among users of inhaled steroids. Epidemiology 2001;12:229-234.
• Meier CR, Schlienger RG, Jick H. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Brit J Clin Pharmacol 2001;52:179-184.
• Kaye JA, Melero-Montes MM, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time-trend analysis. BMJ 2001;322:460-3.
• Kaye JA, Melero-Montes MM, Jick H.  Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: a time-trend analysis. West J Med 2001;174:387-390.
• Schlienger RG, Haefeli WE, Jick H, Meier CR. Risk of cataract in patients treated with statins. Arch Int Med 2001;161:2021-2026.
• Jick H, Vasilakis-Scaramozza C, Jick SS. Live attenuated polio vaccine and the risk of intussusception. Brit J Clin Pharmacol 2001;52:451-453.
• Kaye JA, Myers MW, Jick H. Acetaminophen and the risk of renal and bladder cancer in the General Practice Research Database. Epidemiology 2001;12:690-694.
• Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. (Research Letter). Lancet 2001;358:1427-29.

 2000

• Meier CR, Derby LE, Jick SS, Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.  Arch Int Med 2000;160:349-353.
• Gasse C, Derby LE, Vasilakis C, Jick H. Risk of suicide among users of calcium channel blockers: population based, nested case-control study. BMJ 2000;320:1251.
• Derby LE, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol 2000;105:912-6.
• Myers MW, Vasilakis C, Kaufman MR, Jick H. Antihypertensive drugs and the risk of idiopathic aplastic anemia. Brit J Clin Pharmacol 2000;49:604-608.
• Eland IA, Huerta-Alvarez C, Stricker BHCh, García Rodríguez LA. The risk of acute pancreatitis associated with acid-suppressing drugs. Brit J Clin Pharmacol 2000;49:473-478.
• García Rodríguez LA, Huerta-Alvarez C. Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. Epidemiology 2000;11:376-381.
• García Rodríguez LA, Varas C, Patrono C. Differential effects of aspirin and nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women. Epidemiology 2000;11:382-387.
• Ruigómez A, García Rodríguez LA, Dev VJ, Arellano F, Raniwala J. Are schizophrenia or antipsychotic drugs a risk factor for cataracts? Epidemiology 2000;11:620-3.
• De Abajo FJ, Jick H, Derby LE, Jick SS, Schmitz SM. Intracranial hemorrhage and use of selective serotonin reuptake inhibitors. Brit J Clin Pharmacol 2000;50:43-47.
• Jick SS. The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen and piroxicam in the GPRD. Pharmacotherapy 2000;20:741-744.
• Meier CR. Antibiotics in the prevention and treatment of coronary heart disease. J Infectious Dis 2000;181(suppl 3):S558-S562.
• Meier CR, Napalkov PN, Wegmueller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilization associated with influenza in the United Kingdom. Europ J Clin Microbiol & Infect Dis 2000;19:834-42.
• Jick SS, Maradit Kremers H, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide and attempted suicide. Arch Dermatol 2000;136:1231-1236.
• Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 2000;283:3205-3210.
• Gasse C, Derby LE, Vasilakis-Scaramozza C, Jick H. Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy 2000;20:629-634.
• Kaye JA, Derby LE, Melero-Montes MM, Quinn M, Jick H. The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data.  Brit J Cancer 2000;83:1556-1558.
• Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet 2000;356:1219-1223.
• Jick H, Kaye JA, Vasilakis-Scaramozza C, Jick SS. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis. BMJ 2000;321:1190-5.
• Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000;356:1627-31.
• Ruigómez A, García Rodríguez LA, Hasselgren G, Johansson S, Wallander MA. Overall mortality among patients surviving an episode of peptic ulcer bleeding J Epidemiology & Community Health 2000;54:130-133.
• Lanes SF, Garcia Rodriguez LA, HwangG E. Baseline risk of gastrointestinal disorders among new users of meloxicam, ibuprofen, diclofenac, naproxen and indomethacin. Pharmacoepidemiology and Drug Safety. 2000;9:113-117.
• García Rodríguez LA, Ruigómez A, Wallander MA, Johannson S, Olbe I. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scandinav J Gastroenterol 2000;3:306-311.
• Varas-Lorenzo C, García Rodríguez LA, Pérez-Gutthann S, Duque-Oliart A. Hormone replacement therapy and the incidence of acute myocardial infarction: A population-based case-control study. Circulation 2000;101:2572-2578.
• Melero Montes MM, Jick H. Hyperemesis gravidarum and the sex of the baby. Epidemiology 2000;12:123-4.

 1999

• Meier CR. The possible role of infections in acute myocardial infarction. Biomedicine & Pharmacotherapy 1999;53:397-404.
• Vasilakis C, Jick H, Melero-Montes MM. Risk of idiopathic VTE in users of progestogens. (Research Letter) Lancet 1999;354:1610-1611.
• Jick SS, Stender M, Myers, MW. The frequency of liver disease in type 2 diabetes patients treated with oral hypoglycemic agents. Diabetes Care 1999;22:2067-2071.
• Jick SS, Myers, MW, Jick H. Risk of idiopathic cerebral hemorrhage in women using oral contraceptives with differing progestogen components (Research Letter). Lancet 1999;354:302-303.
• Vasilakis C, Jick SS, Jick H. The risk of VTE in users of postcoital contraceptive pills. Contraception 1999;59:79-83.
• Derby LE, Myers MW, Jick H. Use of dexfenfluramine, fenfluramine and phentermine and risk of stroke. Brit J Clin Pharmacol 1999;47:565-569.
• Jick SS. Fluconazole exposure in pregnancy. Pharmacotherapy 1999;19(2):221-222.
• Sturkenboom MCJM, Meier CR, Jick H, Stricker BHCh. Minocycline and lupus-like syndrome in acne patients. Arch Int Med 1999;159:493-497.
• Meier CR. The possible role of infections in acute myocardial infarction. Biomed & Pharmacother 1999;53:397-404.
• Meier CR, Derby LE, Jick SS, Vasilakis C, Jick H. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 1999;281:427-431.

 1998

• Meier CR. Seasonal variations in the incidence of acute myocardial infarction (letter). JACC 1998;32:2103-4.
• Jick H. Retinoids and teratogenicity. J Am Acad Dermatol 1998;39:S118-22.
• Jick H. CCBs and cancer. Cardiovascular Drugs and Therapy 1998;12:509-510.
• Jick H, Garcia Rodriguez LA, Pérez Gutthann S. Principles of epidemiologic research on adverse and beneficial drug effects. The Lancet 1998;352:1767-1770.
• Jick H, Vasilakis C, Weinrauch LA, Meier CR, Jick SS, Derby LE. A population-based study of users of dexfenfluramine, fenfluramine and phentermine to estimate the risk of clinically diagnosed idiopathic valvular heart disorders. N Engl J Med 1998;339:719-724.
• Myers MW, Jick H. Terfenadine and risk of acute liver disease. Brit J Clin Pharmacol1998;46:251-3.
• Jick H, Derby LE, Vasilakis C, Fife D. The risk of seizures associated with tramadol. Pharmacotherapy 1998;18:607-611.
• Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory tract infections and risk of first-time acute myocardial infarction. The Lancet 1998;351:1467-1471.
• Jick SS, Vasilakis C, Jick H. Pregnancies and terminations after 1995 warning about third-generation oral contraceptives. Lancet 1998;351:1404-5.
• Meier CR, Jick H. Tamoxifen and risk of idiopathic venous thromboembolism. Brit J Clin Pharmacol 1998;45:608-612.
• Meier CR, Sturkenboom MCJM, Cohen AS, Jick H. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatology 1998;25:1515-9.
• Jick SS, Vasilakis C, Martinez C, Jick H. A study of the relation of exposure to quinolones and suicidal behaviour. Brit J Clin Pharmacol 1998;45:77-81.
• Lancaster T, Jick H, Swart AM. Risk of serious haematological toxicity associated with the use of chloramphenicol eye drops.  Brit Med J 1998;316:667.
• Derby LE, Jick H. Prior appendectomy protects against ulcerative colitis. Epidemiology 1998;9:205-7.

 1997

• Meier CR, Jick H. Omeprazole, other antiulcer drugs and newly diagnosed gout. Brit J Clin Pharmacol 1997;44:175-178.
• Meier CR, Jick H. Omeprazole, H2-blockers and polyarthralgia. Brit Med J 1997;315:1283.
• Garcia Rodriguez LA, Ruigómez A, Jick H.  A review of epidemiologic research on drug-induced acute liver injury using the General Practice Research Database in the U.K. Pharmacotherapy 1997;17:721-728.
• Jick H. A database worth saving (commentary). The Lancet 1997;350:1045-1046.
• Meier CR, Jick H. Drug use and pulmonary death rates in increasingly symptomatic asthmatics in the U.K. Thorax 1997;52:612-617.
• Jick H, Jick SS, Derby LE, Vasilakis C, Myers MW, Meier CR. Calcium channel blockers and risk of cancer. The Lancet 1997;349:525-528.
• Jick H, Vasilakis C, Derby LE. Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension. Epidemiology 1997;8(4):446-448.
• Myers, MW, Jick H. Hospitalization for serious blood and skin disorders following trimethoprim/sulfamethoxazole. Brit J Clin Pharmacology 1997;43:446-448.
• Jick SS, Terris BZ. Anticonvulsants and congenital malformations. Pharmacotherapy 1997;17:561-564. 
• Jick S. Ciprofloxacin safety in a pediatric population. The Pediatric Infectious Disease Journal 1997;16:130-134.

 1996

• Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. The risk of hospitalization for idiopathic venous thromboembolism among users of postmenopausal estrogens. The Lancet 1996;348:981-983.
• Jick H, Jick SS, Myers MW, Vasilakis C. Risk of acute myocardial infarction and low dose combined oral contraceptives (letter).  The Lancet 1996;347:627-8.
• Turnbull SJ, Ward A, Treasure JL, Jick H, Derby LE. The demand for eating disorder care. An epidemiological study using the General Practice Research Database. Brit J Psychiatry 1996;169:705-712.
• Gillespie WJ, Henry DA, O'Connell DL, Kendrick S, Juszczak E, McInneny K, Derby L. The development of haematopoietic cancers after implantation of total joint replacement. Results of two cohort studies and overview of the published evidence. Clinical Orthopaedics 1996;329S:S290-S296. 
• Jick H, Derby LE, Gurewich V, Vasilakis C. The risk of myocardial infarction in persons with uncomplicated essential hypertension associated with antihypertensive drug treatment. Pharmacotherapy 1996;16(3):321-326.
• Johnson AG, Jick SS, Perera DR, Jick H. H2 Antagonists and Gastric Cancer. Epidemiology 1996;7:434-436.
• Derby LE, Tennis P, Jick H. Sudden unexplained death among subjects with refractory epilepsy. Epilepsia 1996;37(10):931-935.
• Derby LE, Jick H. Acetaminophen and renal and bladder cancer. Epidemiology 1996;7:358-362.

 1995

• Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptive with differing progestagen components. The Lancet 1995;346:1589-93.
• Jick SS, Myers, MW. A safety study of Danazol. Pharmacotherapy 1995;15:740-1.
• Jick H, Derby, LE. A large population-based follow-up study of trimethoprim/sulfamethoxazole, trimethoprim, and cephalexin users for certain uncommon serious drug toxicity. Pharmacotherapy 1995;15:428-432.
• Jick H, Derby, LE. A large population-based follow-up study of trimethoprim/sulfamethoxazole, trimethoprim, and cephalexin users for certain uncommon serious drug toxicity (letter). The Lancet 1995;345:1118-1119.
• Jick H. Drug-associated asymptomatic elevations of transaminase in drug safety assessment. Pharmacotherapy 1995;15:23-25.
• Jick SS, Dean AD, Jick H. Antidepressants and fatal suicide. Brit Med J 1995;310:215-218.
• Jick H, Myers MW, Dean AD. Sulfasalazine and mesalazine associated blood disorders. Pharmacotherapy 1995;15(2):176-181.
• Jick H, Withers JM, Dean AD. Haemophilus influenza vaccine (letter). Brit J General Practice 1995;45(391):107.

 1994

• Terris BZ, Jick SS, Beeman DW, Jick H. Frequency of adverse events among users of Talwin Nx. Pharmacoepidemiology and Drug Safety 1994;3:351-4.
• Jick H, Derby LE, Dean AD, Henry DA. Flucloxacillin and cholestatic hepatitis (letter).  The Medical Journal of Australia 1994;160:525.
• Garcia Rodriguez LA, Jick H. The risk of upper gastrointestinal bleeding and/or perforation associated with individual nonsteroidal anti-inflammatory drugs. The Lancet 1994;343:769-72.
• Garcia Rodriguez LA, Jick H. Comparison of the risk of gynaecomastia associated with cimetidine, omeprazole and other antiulcer medications. Brit Med J 1994;308:503-6.
• Garcia Rodriguez LA, Williams R, Derby LE, Dean AD, Jick H. Acute liver injury associated with non-steroidal anti-inflammatory drugs and the role of risk factors. Arch Int Med 1994;154:311-316.

 1993

• Jick SS, Walker AM, Jick H. Oral contraceptives and endometrial cancer. Obstet Gynecol 1993;82:931-5.
• Jick SS, Jick H, Dean AD. A follow-up safety study of ciprofloxacin users. Pharmacotherapy 1993;13:461-4.
• Jick SS. Combined estrogen and progesterone use and endometrial cancer (letter). Epidemiology 1993;4:384.
• Derby LE, Pérez Gutthann S, Jick H, Dean AD. Liver disorders in patients receiving chlorpromazine or isoniazid. Pharmacotherapy 1993;13:353-8.
• Derby LE, Jick H, Henry DA, Dean AD. Erythromycin-associated cholestatic hepatitis. Med J Australia 1993;158:600-602.
• Derby LE, Jick H, Henry DA, Dean AD. Cholestatic hepatitis associated with flucloxacillin. Med J Australia 1993;158:596-600.
• Jick SS, Terris BZ, Jick H. First trimester topical tretinoin use and congenital disorders. Lancet 1993;341:1181-2.
• Jick H, Derby LE, Garcia Rodriguez LA, Jick SS, Dean AD. Nonsteroidal anti-inflammatory drugs and certain rare serious events. A cohort study. Pharmacotherapy 1993;13;212-217.
• Jick SS, Walker AM, Jick H. Estrogens, progesterone and endometrial cancer. Epidemiology 1993;4:20-24.

 1992

• Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiology & Drug Safety 1992;1:347-349.
• Jick H, Ulcickas M, Dean A. Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin or trazodone. Pharmacotherapy 1992;12:451-4.
• Mannino S, Garcia Rodriguez LA, Jick SS. NSAIDs, quinolones and convulsions: an epidemiologic approach. Post Marketing Surveillance 1992;6:119-128.
• Jick H. Report on other drug use among persons previously reported to have received intravenous cimetidine (letter). Arch Int Med 1992;152:2145.
• Milunsky A, Morris JS, Jick H, Rothman KJ, Ulcickas M, Jick SS, Shoukimas P, Willett W. Maternal zinc and fetal neural tube defects. Teratology 1992;46:341-348.
• Derby LE, Jick H, Dean AD. Antidepressant drugs and suicide. J Clin Psychopharmacol 1992;12:235-240.
• Jick SS, Jick H, Knauss TA, Dean AD. Antidepressants and convulsions. J Clin Psychopharmacol 1992;12:241-5.
• Orlander JD, Jick SS, Dean AD, Jick H. Urinary tract infections and estrogen use in older women. J Am Geriatrics Soc 1992;40:817-820.
• Milunsky A, Ulcickas M, Willett W, Rothman KJ, Jick SS, Jick H. Maternal heat exposure and neural tube defects. JAMA 1992;268:882-5.
• Jick H, Derby LE, Garcia Rodriguez LA, Jick SS, Dean AD. Liver disease associated with diclofenac, naproxen and piroxicam. Pharmacotherapy 1992;12:207-212.
• Jick SS, Cole TB, Mesher RA, Tennis P, Jick H. Sudden unexplained death in young persons with primary epilepsy. Pharmacoepidemiology and Drug Safety 1992;1:59-64.